Human Papillomavirus (HPV)
CROI 2014: Natural History of HIV-Related Anal Dysplasia [VIDEO]
- Details
- Category: Anal & Cervical Cancer
- Published on Tuesday, 11 March 2014 00:00
- Written by Gregory Fowler
The progression of anal dysplasia is highly variable in people with HIV, progressing in some and remaining stable or regressing in others, according to a retrospective analysis of nearly 3000 participants presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) last week in Boston. Progression to invasive anal cancer, however, was uncommon.
Black Women More Likely to Carry Human Papillomavirus Strains Not Covered by Vaccines
- Details
- Category: HPV Vaccines
- Published on Wednesday, 30 October 2013 00:00
- Written by Duke University
African-American women with precancerous cervical abnormalities are about half as likely to have cancer-causing human papillomavirus (HPV) types 16 and 18, and more likely to have other types for which the Gardasil and Cervarix vaccines do not provide protection, according to a study presented at the American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research taking pace this week in Maryland.
EACS 2013: Anal Cancer Screening May Be Appropriate for All Women with HIV
- Details
- Category: Cancer/Malignancies
- Published on Thursday, 17 October 2013 00:00
- Written by Keith Alcorn
Women living with HIV had a higher risk of anal pre-cancerous changes than cervical changes linked to human papillomavirus (HPV), French researchers reported at the 14th European AIDS Conference this week in Brussels. They suggested that all women with HIV ought to be screened routinely for pre-cancerous changes in the anal canal.
EACS 2013: Ensuring Good Quality HIV Care in Europe: Where Can We Improve?
- Details
- Category: Cascade of Care
- Published on Monday, 21 October 2013 00:00
- Written by Keith Alcorn
Only 20% of people with HIV in Europe have fully suppressed viral load, compared to an estimated 24% in sub-Saharan Africa, despite much higher rates of HIV diagnosis in the European region, Professor Jens Lundgren of the University of Copenhagen told the 14th European AIDS Conference in Brussels on Saturday.
IDWeek 2013: HIV+ Young Women Have Adequate Response to Human Papillomavirus Vaccine
- Details
- Category: HPV Vaccines
- Published on Tuesday, 15 October 2013 00:00
- Written by Liz Highleyman
HIV positive girls did not respond as well to the quadrivalent human papillomavirus (HPV) vaccine as HIV negative girls of the same age, but they responded as well as HIV negative older women, probably giving them sufficient protection from infection, according to a late-breaker presentation at the recent IDWeek conference in San Francisco.
Web Design and Development by